Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment - Wikidata - wikimedia - TriplyDB

Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment

Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment

http://www.wikidata.org/entity/Q33808209

about

Hematopoietic stem cell expansion and generation: the ways to make a breakthrough Novel Techniques for Ex Vivo Expansion of Cord Blood: Clinical Trials Advances in umbilical cord blood manipulation-from niche to bedside Advances in unrelated and alternative donor hematopoietic cell transplantation for nonmalignant disorders Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!Umbilical Cord Blood Transplantation: Challenges and Future Directions.Engineering cord blood to improve engraftment after cord blood transplant.Prolonged Growth Hormone/Insulin/Insulin-like Growth Factor Nutrient Response Signaling Pathway as a Silent Killer of Stem Cells and a Culprit in Aging.Hematopoietic stem cell transplantation for patients with sickle cell disease: progress and future directions.Thrombopoietin treatment of one graft in a double cord blood transplant provides early platelet recovery while contributing to long-term engraftment in NSG mice.Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation.Bioengineering a human plasma-based epidermal substitute with efficient grafting capacity and high content in clonogenic cells Banking or Bankrupting: Strategies for Sustaining the Economic Future of Public Cord Blood Banks.Better allele-level matching improves transplant-related mortality after double cord blood transplantation.Genetic editing of HLA expression in hematopoietic stem cells to broaden their human application.High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia.Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft Enhancing the efficacy of engraftment of cord blood for hematopoietic cell transplantation Expansion of Human Tregs from Cryopreserved Umbilical Cord Blood for GMP-Compliant Autologous Adoptive Cell Transfer Therapy.Umbilical cord blood donation: public or private?Ex vivo expansion of hematopoietic stem cells.Cellular engineering and therapy in combination with cord blood allografting in pediatric recipients.Clinical risks and healthcare utilization of haematopoietic cell transplantation for sickle cell disease in the U.S. using merged databases.Methods of ex vivo expansion of human cord blood cells: challenges, successes and clinical implications.Cord blood transplant for acute myeloid leukaemia.Immune reconstitution and outcomes after conditioning with anti-thymocyte-globulin in unrelated cord blood transplantation; the good, the bad, and the ugly.Advances in umbilical cord blood cell therapy: the present and the future.Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.Optimizing autologous cell grafts to improve stem cell gene therapy.Haematopoietic stem cell transplantation for sickle cell disease - current practice and new approaches.Individualized conditioning regimes in cord blood transplantation: Towards improved and predictable safety and efficacy.Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells from Umbilical Cord Blood.Awareness of cord blood collection and the impact on banking.The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter II: emerging transformational cytotherapies.Novel strategies for improving hematopoietic reconstruction after allogeneic hematopoietic stem cell transplantation or intensive chemotherapy.Hematopoietic cell transplantation in Fanconi anemia: current evidence, challenges and recommendations.Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization.3D models of the hematopoietic stem cell niche under steady-state and active conditions.Immobilisation of Delta-like 1 ligand for the scalable and controlled manufacture of hematopoietic progenitor cells in a stirred bioreactor.Recombinant TAT-BMI-1 fusion protein induces ex vivo expansion of human umbilical cord blood-derived hematopoietic stem cells.

P2860

Q26771763-80E2CB7B-A71F-414C-86F9-84058CEF7928 Q26772216-7C65D2F9-1750-46F8-B00B-46CB8D368B59 Q26824305-006A0DEA-95A2-4CF8-8009-B8F8B9C24185 Q27022561-2671FE86-799E-4DB2-917E-C4B55C914C84 Q30252339-3A4463AB-6339-4355-9E20-C91C9550AB2C Q30352323-4C6B1287-D827-4A99-B37F-0616CCB2F36A Q33766995-9BE3B9BD-375B-4628-AA5D-33ACB505E46D Q33861285-0F4E6DE2-572B-4903-8511-B98AA3538EA4 Q34625467-3B5090E0-BD6A-4021-A0FA-9FE32D85E582 Q34751263-D003F346-FE4F-42FD-ACCE-105F13ECFC74 Q35583385-F73F88EB-FB09-41C2-8BE1-2EB076A26B78 Q35665288-029243DA-78B1-44EC-92DD-97C40A4EF195 Q35856939-A0C8623D-F144-45F6-BA37-EB0E1A9A6C18 Q36115699-2B4F342B-5EFB-415C-A979-D8185423ADF8 Q36605814-7CF3A2B7-20A6-4143-AA81-C31A68A160F4 Q36622322-DB66A572-5F2D-437E-AA3D-4A7FB6CC7BB3 Q36938847-884601B6-CD84-4416-9470-D056E0DA36EC Q36984624-CADB919A-F13E-4234-A9EF-4FE264BB9EA4 Q37717910-ADB4958D-CAD3-446A-AB0E-4FCA0BE25228 Q38510475-94799408-377E-4C4E-8E1A-3EF2979C199D Q38561480-1514DC3F-8F97-474F-93C8-B0F253004A65 Q38586429-AC294F4E-0C71-402C-84B5-069E3AF04A64 Q38619234-CAE56A59-6984-48E1-8EAD-83BE0C5CA7F6 Q38658670-08BDDBFC-1B27-4F29-9A97-CAF2A931BE74 Q38696346-28A4BF33-063F-4FDC-BD1B-FBF89FC91ED4 Q38728525-447C879F-EF72-4554-B909-7AC055404470 Q38734758-9AB735E7-58F8-499F-AAFD-AE6508810737 Q38747929-52A9FC01-CED4-4680-BE76-C4F4D4519C77 Q38815488-8D1C0ACF-E7BC-435F-ADCB-FD8A7ED83CE6 Q38851953-888756D4-B40A-4417-BD71-77CAAA43A51A Q38897538-21377EEA-1B83-4C22-9EB3-8291A9945440 Q38994507-98B5401A-D9CD-4518-B5E5-06287F2EFAC2 Q39006110-50319621-CCB1-4689-94C6-C009B1976B2B Q39012031-58E93FBE-E429-49D6-B8B9-D14B60029A0E Q39031745-3BF09D29-3AEC-4A5F-A182-7E1E943A8482 Q39032775-59E6D47A-4E59-40F7-8496-BE9325055252 Q40258805-A1493BA0-C496-4046-9CF6-38CF6760162D Q40965643-058C4D97-DD22-4F9D-9F44-04CD4CC9E185 Q41263076-D4D0CDC3-FFE4-4254-8700-F9FC1903E32E Q41279525-38A077B9-DA30-43F4-B94D-7DC126BD83D7

P2860

Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment

http://www.wikidata.org/entity/Q33808209

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Umbilical cord blood expansion ...... -term multilineage engraftment

@ast

Umbilical cord blood expansion ...... -term multilineage engraftment

@en

type

label

Umbilical cord blood expansion ...... -term multilineage engraftment

@ast

Umbilical cord blood expansion ...... -term multilineage engraftment

@en

prefLabel

Umbilical cord blood expansion ...... -term multilineage engraftment

@ast

Umbilical cord blood expansion ...... -term multilineage engraftment

@en

P1433

Q33808209-215AA386-6781-4F03-88E1-0CD8913BB5B9

P1476

Q33808209-5B270A2D-BAFF-411E-A95C-C90C867B8A0C

P2093

Q33808209-079FFDF5-3E2E-46C5-8C96-A04393DDC0FE

Q33808209-0FBCE388-F0AD-420C-8352-DA22CC63DC0E

Q33808209-121CABF1-1CDA-4A26-ADA7-64D3F1FCC3DD

Q33808209-20A756F2-6289-4895-8F97-7B08C456355C

Q33808209-23FB289F-3108-443C-9B45-9A317169BD75

Q33808209-3C8EE2EE-E896-441B-AD9C-57AB710D09F9

Q33808209-409B5581-381C-416E-9C13-02470C7913A7

Q33808209-56F54F44-AE2F-42FD-A54D-0D410C7AEE6B

Q33808209-5D8DE320-75EC-4E54-B3C6-88091A21D2F9

Q33808209-6B231570-7B2F-4959-86EA-412F01CC19E4

P2860

Q33808209-0869191E-D4C7-4A64-8DFF-932B4EA91D16

Q33808209-131A5FA3-F437-473D-9CA4-CEB1EC6B7280

Q33808209-235A38D1-F8FC-4AD8-B656-C8B1A0086B96

Q33808209-2CD8B2A7-D095-442C-8526-7513FC4052AC

Q33808209-33D8BFFF-BBA1-4E9A-AD36-8D3FCA3835B7

Q33808209-3FA8B00A-A70D-4896-BDE0-F37740917CA6

Q33808209-56F23067-96D8-4FE1-98CD-2B058A6D0C7A

Q33808209-78C2B7FF-1872-4FF3-B705-78AC474332F4

Q33808209-7DFAC1B8-0AA4-49E4-BCE4-33AC302257F8

Q33808209-9084A60C-BBB8-49F1-A546-75B991BBFD9A

P304

Q33808209-04EBA055-A22A-4412-8266-9ED4C2A08137

P31

Q33808209-92BFC07A-8D37-4E0D-AB19-0C809BC07559

P356

Q33808209-078E94AE-8D1C-46C9-92ED-A9DCA8AD572C

P407

Q33808209-2A67BB84-D981-44CC-B36B-648D7F02DAB9

P433

Q33808209-7854E77F-F6C2-4E85-A7C3-57D5E8012BF8

P478

Q33808209-1156744D-88BA-4CF6-9E2E-2B37C103180A

P50

Q33808209-D5A28BE9-DB7A-4259-A696-9FF930DA42C5

P577

Q33808209-C4EF2DEA-DED4-40DF-8BAE-4F710D1DAF12

P5875

Q33808209-76014274-CA52-4897-B658-F9188A37DA4C

P698

Q33808209-A29558A8-E8D4-44E6-8658-3217F251D526

P932

Q33808209-2C8E3C2A-5463-4FFA-B026-0CB7BAB6A304

P356

P1433

Journal of Clinical Investigation

P1476

Umbilical cord blood expansion ...... -term multilineage engraftment

@en

P2093

Amnon Peled

http://www.w3.org/2001/XMLSchema#string

Ashley Morris

http://www.w3.org/2001/XMLSchema#string

Barbara Waters-Pick

http://www.w3.org/2001/XMLSchema#string

Carolyn McDonald

http://www.w3.org/2001/XMLSchema#string

Cristina Gasparetto

http://www.w3.org/2001/XMLSchema#string

David A Rizzieri

http://www.w3.org/2001/XMLSchema#string

David Snyder

http://www.w3.org/2001/XMLSchema#string

Dima Yackoubov

http://www.w3.org/2001/XMLSchema#string

Dorit Aschengrau

http://www.w3.org/2001/XMLSchema#string

Efrat Landau

http://www.w3.org/2001/XMLSchema#string

P2860

Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia

Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis

Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Mar

Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.

Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution.

Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.

Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood

Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis

Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.

Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation.

P304

3121-3128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI74556

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

Keith M. Sullivan

P577

2014-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262942885

http://www.w3.org/2001/XMLSchema#string

P698

24911148

http://www.w3.org/2001/XMLSchema#string

P932

4071379

http://www.w3.org/2001/XMLSchema#string